Brain Calcifications: Genetic, Molecular, and Clinical Aspects
International Journal of Molecular Sciences · 19.05.2023 · 24 (10) · 8995
DOI: 10.3390/ijms24108995 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 19.05.2023. Verfasst von Edoardo Monfrini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy. Hauptthemen laut MEDLINE: Brain Diseases, Calcinosis. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, Cure SMA, Thompson Family Foundation Initiative (TFFI).
Abstract (Originalsprache)
Many conditions can present with accumulation of calcium in the brain and manifest with a variety of neurological symptoms. Brain calcifications can be primary (idiopathic or genetic) or secondary to various pathological conditions (e.g., calcium–phosphate metabolism derangement, autoimmune disorders and infections, among others). A set of causative genes associated with primary familial brain calcification (PFBC) has now been identified, and include genes such as SLC20A2, PDGFB, PDGFRB, XPR1, MYORG, and JAM2. However, many more genes are known to be linked with complex syndromes characterized by brain calcifications and additional neurologic and systemic manifestations. Of note, many of these genes encode for proteins involved in cerebrovascular and blood–brain barrier functions, which both represent key anatomical structures related to these pathological phenomena. As a growing number of genes associated with brain calcifications is identified, pathways involved in these conditions are beginning to be understood. Our comprehensive review of the genetic, molecular, and clinical aspects of brain calcifications offers a framework for clinicians and researchers in the field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Dino Ferrari Center, Neuroscience Section, Department of Pathophysiology and Transplantation, University of Milan, 20122 Milan, Italy.
- Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, 20122 Milan, Italy.
- Columbia University Irving Medical Center, Center for Motor Neuron Biology and Diseases, Departments of Pathology & Cell Biology and Neurology, New York, NY 10032, USA.
- The Marlene and Paolo Fresco Institute for Parkinson's and Movement Disorders, Department of Neurology, NYU Langone Health, New York, NY 10017, USA.
ORCID-Profile: Edoardo Monfrini, Giulietta M Riboldi
Förderung
- NINDS NIH HHS
- Cure SMA
- Thompson Family Foundation Initiative (TFFI)
- Project-ALS
- National Institute of Health
- Michael J Fox Foundation
- Parkinson’s Foundation
- Department of Defense
Zitieren
APA
Monfrini, E., Arienti, F., Rinchetti, P., Lotti, F., & Riboldi, G. M. (2023). Brain Calcifications: Genetic, Molecular, and Clinical Aspects. International Journal of Molecular Sciences, 24(10), 8995. https://doi.org/10.3390/ijms24108995
Vancouver
Monfrini E, Arienti F, Rinchetti P, Lotti F, Riboldi GM. Brain Calcifications: Genetic, Molecular, and Clinical Aspects. International Journal of Molecular Sciences. 2023;24(10):8995. doi:10.3390/ijms24108995
BibTeX
@article{Monfrini2023,
author = {Monfrini, Edoardo and Arienti, Federica and Rinchetti, Paola and Lotti, Francesco and Riboldi, Giulietta M},
title = {Brain Calcifications: Genetic, Molecular, and Clinical Aspects},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {10},
pages = {8995},
doi = {10.3390/ijms24108995}
}
EUVIMED